for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-ISR Initiates Collaboration With Chinese InnoStar For The Treatment Of Hepatitis B

Jan 15 (Reuters) - ISR Immune System Regulation Holding AB :

* CO’S BOARD OF DIRECTORS DECIDED ON TUESDAY TO INITIATE STRATEGIC COLLABORATION WITH RENOWNED CHINESE CRO COMPANY SHANGHAI INNOSTAR BIOTECH

* THE GOAL OF THE COLLABORATION IS TO DEVELOP ISR’S DRUG CANDIDATE ISR050 FOR TREATMENT OF HEPATITIS B

* CO’S DRUG CANDIDATE IS NOW IN FINAL STAGE OF THE PRECLINICAL PHASE

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up